Adeia Inc. Logo

Adeia Inc.

Invents and licenses foundational IP for the media and semiconductor industries.

ADEA | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
3025 ORCHARD PARKWAY, 95134 SAN JOSE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Adeia Inc. is a research and development (R&D) and intellectual property (IP) licensing company that invents, develops, and licenses foundational innovations for the media, entertainment, and semiconductor industries. The company's extensive patent portfolio in the media sector powers technologies for content search, discovery, and recommendation across over-the-top (OTT) streaming and pay-TV platforms. In the semiconductor space, Adeia provides foundational IP licenses. By offering access to its innovations, Adeia aims to accelerate the adoption of advanced technologies for its partners and customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adeia Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adeia Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Adeia Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572
CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan 3688

Talk to a Data Expert

Have a question? We'll get back to you promptly.